A new application about 59564-59-9

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 59564-59-9, and how the biochemistry of the body works.category: quinoxaline

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 59564-59-9, name is 3,4-Dihydroquinoxalin-2(1H)-one, introducing its new discovery. category: quinoxaline

NOVEL HETEROCYCLIC CARBOXAMIDES AS M1 AGONISTS

The present invention relates to novel M1 agonistic compounds of formula (I) and their use in the treatment of cognitive impairment associated i.a. with schizophrenia and in the treatment of other diseases mediated by the muscarinic M1 receptor.

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 59564-59-9, and how the biochemistry of the body works.category: quinoxaline

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N139 | ChemSpider